You are viewing: India Microbiome Diagnostics Market analysis
Part of: Microbiome Diagnostics Market (Global)

The India Microbiome Diagnostics Market was valued at $4.1 Million in 2023 and projected to reach to $9.3 Million by 2028, representing a compound annual growth rate of CAGR 17.8%. India's microbiome diagnostics market is poised for substantial growth, expanding from $4.1 million in 2023 to $9.3 million by 2028.

India Microbiome Diagnostics Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Microbiome Diagnostics Market Trends and Insights

  • This expansion in India reflects increasing healthcare awareness, rising prevalence of gastrointestinal disorders, and growing adoption of precision medicine approaches across the country.
  • India's market growth outpaces global trends, driven by a large patient population, improving diagnostic infrastructure, and expanding healthcare accessibility in both urban and emerging markets. The microbiome diagnostics sector in India is benefiting from technological advancements and increased investment in healthcare innovation.
  • India's pharmaceutical and diagnostic companies are increasingly recognizing the clinical and commercial potential of microbiome-based testing for conditions ranging from inflammatory bowel disease to metabolic disorders.
  • By 2028, India is expected to establish itself as a significant regional hub for microbiome diagnostics, supported by cost-effective manufacturing capabilities and a growing pool of skilled healthcare professionals dedicated to advancing personalized medicine..

Key Market Statistics

  • CAGR (2023-2028) CAGR 17.8%
  • Market Size, 2023 ~USD 4.1 Million
  • Forecast, 2028 ~USD 9.3 Million
  • Country India

India Microbiome Diagnostics Market Overview

Rapid Market Expansion :

India's microbiome diagnostics market is growing at 17.8% CAGR, significantly outpacing the global rate of 15.5%, driven by increasing healthcare investments and diagnostic infrastructure development across tier-2 and tier-3 cities.

Rising GI Disorder Prevalence :

Growing incidence of gastrointestinal disorders, irritable bowel syndrome, and inflammatory bowel conditions in India is fueling demand for advanced microbiome diagnostic solutions among both urban and semi-urban populations.

Precision Medicine Adoption :

Indian healthcare providers are increasingly embracing precision medicine and personalized treatment approaches, with microbiome diagnostics becoming integral to tailored therapeutic interventions and preventive healthcare strategies.

Healthcare Awareness Growth :

Enhanced health consciousness among Indian consumers, coupled with digital health initiatives and government-backed diagnostic programs, is accelerating adoption of microbiome testing across hospitals, diagnostic centers, and wellness clinics.

India Microbiome Diagnostics Market Dynamics

  • This trajectory reflects structural shifts in healthcare delivery, including increased penetration of diagnostic services in rural areas, growing partnerships between diagnostic companies and healthcare providers, and rising patient awareness about gut health's role in overall wellness.
  • The market is benefiting from India's large patient population and improving healthcare infrastructure investments. Key growth catalysts include government initiatives promoting diagnostic accessibility, rising disposable incomes enabling premium diagnostic services, and growing clinical validation of microbiome-based treatments.
  • As Indian healthcare systems increasingly adopt advanced diagnostics for disease prevention and management, microbiome testing is expected to transition from niche specialty services to mainstream diagnostic offerings, particularly in gastroenterology, immunology, and preventive medicine segments..

Related Ecosystem

Key Takeaways

  • India's microbiome diagnostics market is valued at $4.1 million in 2023 and is forecast to reach $9.3 million by 2028, growing at a 17.8% CAGR.
  • India's market growth rate exceeds the global average, driven by large patient populations and expanding healthcare infrastructure.
  • India is positioning itself as a regional leader in microbiome diagnostics through cost-effective innovation and diagnostic advancement.
  • Rising prevalence of gastrointestinal and metabolic disorders in India is accelerating demand for microbiome-based diagnostic solutions.

Microbiome Diagnostics Market Report Scope

Report Metric Details
Base Year 2023
Fastest Growing Segment SHOTGUN METAGENOMICS (Technology)
Forecast Period 2023-2028
Growth Rate CAGR of 15.5% from 2023 to 2028
Largest Segment DISEASE DIAGNOSTIC APPLICATIONS (Application)
Market Size Base Year (Billions) ~USD 0.15 (2023)
Revenue Forecast (Billions) ~USD 0.3 (2028)
Segments Covered Product, Technology, Sample, Application, Type, End User

India Microbiome Diagnostics Market Report Segmentation

6 segment dimensions are covered across the global market.

By Product

  • Instruments
  • Kits & Reagents

By Technology

  • 16S Rrna Sequencing
  • Metatranscriptomics
  • Other Technologies
  • Shotgun Metagenomics

By Sample

  • Fecal Samples
  • Other Samples
  • Saliva Samples
  • Skin Samples

By Application

  • Disease Diagnostic Applications
  • Research Applications

By Type

  • Gastrointestinal Disorders
  • Metabolic Disorders
  • Other Disease Diagnostic Applications

By End User

  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes

INDIA: MICROBIOME-BASED DIAGNOSTICS MARKET, BY END USER, 2021–2028

Segment20212022202320242025202620272028CAGR (%)
HOSPITALS2.12.52.93.444.75.46.517.5
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES0.20.20.20.20.30.30.40.414.9
RESEARCH INSTITUTES0.70.811.21.41.722.419.1
TOTAL33.54.14.85.76.77.89.317.8

Target Audience

  • Diagnostic Companies & Labs : In-vitro diagnostics manufacturers and laboratory operators need India-specific market data to assess expansion opportunities, develop localized service offerings, and establish partnerships with healthcare providers across Indian cities.
  • Healthcare Providers & Hospitals : Hospital networks and diagnostic centers require market insights to justify investments in microbiome diagnostic capabilities, understand patient demand trends, and integrate these services into their clinical offerings.
  • Pharmaceutical & Biotech Companies : Drug developers and biotech firms need India market intelligence to identify microbiome-based therapeutic opportunities, understand patient populations, and plan clinical trial strategies in this growing market.
  • Medical Device Investors : Private equity firms and venture capital investors targeting India's healthcare sector require detailed market sizing and growth projections to evaluate investment opportunities in microbiome diagnostic startups and established players.
  • Government & Policy Bodies : Healthcare policymakers and government agencies need market data to inform diagnostic infrastructure planning, healthcare spending priorities, and regulatory frameworks supporting microbiome testing accessibility across India.

Reasons to Buy this Report

  • Market Size & Growth Validation : Obtain precise market valuation ($4.1M in 2023) and verified growth projections ($9.3M by 2028) specific to India, enabling accurate business planning, investment decisions, and competitive positioning in this high-growth segment.
  • India-Specific Growth Drivers : Understand localized market dynamics including rising GI disorder prevalence, healthcare awareness trends, and precision medicine adoption patterns unique to India's healthcare ecosystem and consumer behavior.
  • Strategic Market Entry Planning : Leverage India-focused insights to develop targeted go-to-market strategies, identify optimal distribution channels, and prioritize geographic expansion across tier-1, tier-2, and tier-3 cities with highest growth potential.
  • Competitive Intelligence : Benchmark against India's market performance relative to global trends (17.8% vs 15.5% CAGR), identify competitive gaps, and capitalize on India's faster growth rate compared to mature markets.
  • Investment & Partnership Opportunities : Identify high-potential investment targets, partnership opportunities with Indian diagnostic providers, and expansion prospects in India's rapidly evolving microbiome diagnostics ecosystem.

Frequently asked questions

What is the current size of India's microbiome diagnostics market?

India's microbiome diagnostics market was valued at $4.1 million in 2023 and is expected to grow to $9.3 million by 2028.

What is the projected growth rate for microbiome diagnostics in India?

India's microbiome diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 17.8% from 2023 to 2028.

What factors are driving growth in India's microbiome diagnostics market?

Key drivers include increasing healthcare awareness, rising prevalence of gastrointestinal disorders, adoption of precision medicine, improved diagnostic infrastructure, and expanding healthcare accessibility across India.

How does India's microbiome diagnostics market compare to global trends?

India's market growth rate of 17.8% CAGR exceeds the global average of 15.5%, reflecting India's strong market potential and healthcare sector expansion.

What role will India play in the Asia Pacific microbiome diagnostics market by 2028?

India is expected to establish itself as a significant regional hub within Asia Pacific, leveraging cost-effective manufacturing, skilled healthcare professionals, and growing clinical adoption of microbiome diagnostics.

RESEARCH METHODOLOGY

The objective of the study is to analyze the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies’ developments such as product launches and approvals, expansions, and partnerships of the leading players, the competitive landscape of the microbiome diagnostic market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the microbiome-based diagnostics market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was collected after acquiring knowledge about the microbiome diagnostics market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as doctors, nurses, and hospital purchase managers) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, Rest of the World. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Microbiome Diagnostics Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue. As of 2022: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

DNA Genotek (US)

Manager

Viome Life Sciences (US)

VP Sales

Genetic Analysis AS (Norway)

Regional Sales Head

Becton, Dickinson and Company (US)

Sales Director

Market Size Estimation

All major product manufacturers offering various microbiome diagnostics were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value microbiome-based diagnostics market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of microbiome diagnostics products at the regional and country level
  • Relative adoption pattern of each product type among key application segments at the regional and/or country-level
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level

Global Microbiome Diagnostics Market Size: Bottom Up Approach

Microbiome Diagnostics Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Microbiome Diagnostics Market Size: Top-Down Approach

Microbiome Diagnostics Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the microbiome-based diagnostics industry.

Market Definition

Microbiom diagnostic products are used to investigate and understand the complex communities of microorganisms living in and on the human body. Microbiome diagnostics involves collecting samples from various body sites, such as the skin, gut, mouth, and other mucosal surfaces, and analyzing the genetic material such as DNA, RNA of the microorganisms within these samples.

Key Stakeholders

  • Manufacturers and distributors of microbiome-based diagnostics products
  • Pharmaceutical and Biotechnology Companies
  • R & D centers
  • Diagnostic laboratories
  • Hospitals and clinics
  • Academic institutes
  • Research institutes
  • Market research and consulting firms

Report Objectives

  • To define, describe, segment, and forecast the global microbiome diagnostics market by product, sample, application, end user and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall microbiome diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the microbiome-based diagnostics market into specific countries/regions in the Rest of Europe, Rest of Asia Pacific, and Rest of the World.

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)

Get the Full Microbiome Diagnostics Market Report

Full forecast, segment splits, and company analysis for all Microbiome Diagnostics Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status